Predictive value of neonatal hearing screening for the early detection of congenital sensorineural hearing loss: Clinical and demographic characteristics of patients with high risk of congenital sensorineural hearing loss according to neonatal hearing screening.
Article Sidebar
Main Article Content
Abstract
Introduction: Neonatal hearing screening is fundamental for the early and accurate detection of hearing impairment in the pediatric population. This study addresses the challenges and factors that influence its diagnostic accuracy in low- and middle-income settings. Objective: To describe the clinical and demographic characteristics of newborns with a high risk of congenital sensorineural hearing loss, as identified through neonatal hearing screening at a tertiary care hospital. Methodology: A cross-sectional study was conducted, including 87 newborns at high risk of congenital sensorineural hearing loss, who were screened between 2021 and 2023 at a tertiary care hospital in Colombia. Results: A total of 87 patients were evaluated (56% male). The median maternal age was 31 years (IQR: 27-35). Mean birth weight and length were 2686 g (SD: 664) and 47.2 cm (SD: 4.2), respectively. Mean gestational age was 37.1 weeks (SD: 2.9). A total of 34% (28/82) of patients required critical care. Jaundice was observed in 32% (24/75), Trisomy 21 in 8 cases (10%), and cleft lip and palate in 8 cases (10%). Conclusion: This study provides a comprehensive overview of the clinical and demographic characteristics of patients with a high risk of congenital sensorineural hearing loss in a high-complexity hospital setting in Colombia.
Article Details
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
How to Cite
References
1. Díaz C, Goycoolea M, Cardemil F. Hipoacusia: trascendencia, incidencia y prevalencia. Revista Médica Clínica Las Condes. 2016;27(6): 731-739.
2. Shave S, Botti C, Kwong K. Congenital Sensorineural Hearing Loss. Pediatr Clin North Am. 2022;69(2):221-234.
3. Reyes Gelves CA, Mejía Perdigón LJ, Carvajalino Monje I, Morón LS, Gelves Rosales JA. Factores de riesgo para el desarrollo de hipoacusia neurosensorial congénita: análisis de 10 años. Acta otorrinolaringol cir cabeza cuello [Internet]. 14 de agosto de 2018 [citado 15 de abril de 2024];42(2):87-92. Disponible en: https://www.revista.acorl.org.co/index.php/ acorl/article/view/139
4. V. Alzina de Aguilar. Detección precoz de la hipoacusia en el recién nacido. 2025:63(3):193-198.
5. Diaz D, et al. Tamizaje auditivo neonatal en pacientes de alto riesgo con otoemisiones acústicas: evaluación de resultados. [Internet]. 2015. [citado: 2024, abril] Disponible en: http://hdl. handle.net/10654/6662
6. Rodríguez González Leiner, Zeledón Díaz Ana Laura, Centeno Mora Óscar. Eficacia del «Programa de tamizaje auditivo neonatal universal» de la Caja Costarricense del Seguro Social en la detección de sordera en niñas y niños, entre 2016 y 2018. PSM [Internet]. 2022;19(2): 204-223.
7. Organización Mundial de la Salud. Addressing the rising prevalence of hearing loss. Ginebra: OMS; 2018 (https://apps. who.int/iris/handle/10665/260336, consultado el 18 de mayo del 2021).
8. Diane C. Thompson; Heather McPhillips; Robert L. Davis; Tracy A. Lieu; Charles J. Homer; Mark Helfand. Universal Newborn Hearing Screening: Summary of Evidence. JAMA. 2001;286(16):2000-2010.
9. Al-Balas HI, Nuseir A, Zaitoun M, Al-Balas M, Khamees A, Al-Balas H. The effects of mode of delivery, maternal age, birth weight, gender and family history on screening hearing results: A cross sectional study. Ann Med Surg (Lond). 2021;64:102236.
10. Ospina-Garcia Juan C., Perez-Garcia Irene C., Guerrero Diana, Sanchez-Solano Nataly J., Salcedo-Betancourt Juan. Prevalence of sensorineural hearing loss in newborns in a hospital from a developing country. Rev. salud pública [Internet]. 2019; 21(1):56-63.
11. Bener A., Eihakeem A.A., Abdulhadi K. Is there any association between consanguinity and hearing loss. Int. J. Pediatr. Otorhinolaryngol. 2005;69(3):327– 333.
12. Xiao T., Li Y., Xiao L., Jiang L., Hu Q. Association between mode of delivery and failure of neonatal acoustic emission test: a retro- spective analysis. Int. J. Pediatr. Otorhinolaryngol. 2015;79:516–519.
13. Karaca CT, Oysu Ç, Toros SZ, Naiboglu B, Verim A. Is hearing loss in infants associated with risk factors? Evaluation of the frequency of risk factors. Clin. Exp. Otorhinolaryngol. 2014;7(4):260–263.
14. Smolkin T, Awawdeh S, Blazer S, Mick O, Makhoul IR. Delayed first otoacoustic emissions test decreases failure on neonatal hearing screening after caesarian delivery. Acta Paediatr. 2013;102(5):e194–e199.
15. Shahid R, Vigilante M, Deyro H, Reyes I, Gonzalez B, Kliethermes S. Risk factors for failed newborn otoacoustic emissions hearing screen. Clin. Pediatr. 2016;55(12):1138–1142.
16. Li A, Gao G, Wang N, Fu T, Zhu F, Zhang X, et al. The characteristic of otoacoustic emissions in full-term neonates according to ABO blood groups. Braz J Otorhinolaryngol. 2020 ;86(6):774-780